Trident Texofab standalone net profit rises 60.00% in the June 2022 quarter

Sales rise 57.05% to Rs 23.40 crore

Net profit of Trident Texofab rose 60.00% to Rs 0.24 crore in the quarter ended June 2022 as against Rs 0.15 crore during the previous quarter ended June 2021. Sales rose 57.05% to Rs 23.40 crore in the quarter ended June 2022 as against Rs 14.90 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales23.4014.90 57 OPM %6.287.72 -PBDT0.740.47 57 PBT0.320.13 146 NP0.240.15 60

Powered by Capital Market - Live News